Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kathiresan Suppiah"'
Testosterone levels and quality of life in diverse male patients with cancers unrelated to androgens
Autor:
Stewart B. Fleishman, Divya Mahajan, Farhan Mohammad, Tahir Mirzoyev, Peter Homel, Michael J. Guarino, Victoria Rosenwald, Mohammad F. Suhail, Rotraud Strebel-Amrhein, Timothy F. Wozniak, Hina Khan, Kathiresan Suppiah
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(34)
Purpose Symptoms secondary to hormonal changes significantly impact quality of life (QoL) in patients with cancer. This cross-sectional study examines prevalence of hypogonadism and its correlation with QoL and sexual dysfunction. Patients and Method
Autor:
Pamela S. Simpson, Jamal Misleh, Gregory A. Masters, Timothy F. Wozniak, Charles J. Schneider, Michael J. Guarino, David D. Biggs, Kathiresan Suppiah, Stephen S. Grubbs
Publikováno v:
Journal of Clinical Oncology. 30:e18122-e18122
e18122 Background: The trial was designed to examine PFS, OS and toxicities of a novel 3 drug combination in advanced NSC lung cancer. The first patient was entered 3/08 and the last in 5/11. Methods: Treatment consisted of Carboplatin AUC 5,Pemetrex
Autor:
Peter Homel, Hina Khan, R. A. Strebel, Stewart B. Fleishman, Kathiresan Suppiah, Victoria Rosenwald, Tahir Mirzoyev, Timothy F. Wozniak, Michael J. Guarino, M. F. Suhail
Publikováno v:
Journal of Clinical Oncology. 28:9140-9140
9140 Background: Symptoms secondary to hormone changes significantly impact QoL in cancer patients. This cross-sectional study examines prevalence of hypogonadism and its correlation with symptoms....
Autor:
Kenneth Pennington, William A. Wegener, David M. Goldenberg, Aldo N. Serafini, Charles J. Schneider, Michael J. Guarino, Kathiresan Suppiah, Robert M. Sharkey, David V. Gold, C. Rocha-Lima
Publikováno v:
Journal of Clinical Oncology. 27:4620-4620
4620 Background: In a phase I study, a single dose of 90Y-labeled anti-mucin humanized antibody, hPAM4 (90Y-hPAM4), led to several transient reductions or stabilization of lesions in advanced pancreatic cancer, with bone marrow toxicity limiting the